162 related articles for article (PubMed ID: 2900351)
1. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. UK Trial of Early Detection of Breast Cancer Group.
Lancet; 1988 Aug; 2(8608):411-6. PubMed ID: 2900351
[TBL] [Abstract][Full Text] [Related]
2. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
[TBL] [Abstract][Full Text] [Related]
3. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
4. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of early detection of breast cancer in Great Britain (author's transl)].
Chamberlain J
Rev Epidemiol Sante Publique; 1981; 29(3):327-34. PubMed ID: 7302314
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with breast cancer diagnosed in the United Kingdom trial of early detection of breast cancer. United Kingdom Trial of Early Detection of Breast Cancer Group.
Moss SM; Ellman R; Coleman D; Chamberlain J
J Med Screen; 1994 Jul; 1(3):193-8. PubMed ID: 8790516
[TBL] [Abstract][Full Text] [Related]
7. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
US Preventive Services Task Force
Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
[TBL] [Abstract][Full Text] [Related]
8. Trial of early detection of breast cancer: description of method.
Br J Cancer; 1981 Nov; 44(5):618-27. PubMed ID: 7032568
[TBL] [Abstract][Full Text] [Related]
9. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
10. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of the Nottingham breast self-examination education programme.
Dowle CS; Mitchell A; Elston CW; Roebuck EJ; Hinton CP; Holliday H; Blamey RW
Br J Surg; 1987 Mar; 74(3):217-9. PubMed ID: 3567517
[TBL] [Abstract][Full Text] [Related]
12. Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme.
Beckett JR; Kotre CJ; Michaelson JS
Br J Radiol; 2003 May; 76(905):309-20. PubMed ID: 12763946
[TBL] [Abstract][Full Text] [Related]
13. Mammographic screening of women aged 40 to 49 years. Is it justified?
Feig SA
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
[TBL] [Abstract][Full Text] [Related]
14. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
Hendriks JH; Verbeek AL
Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
[TBL] [Abstract][Full Text] [Related]
15. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
16. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
[TBL] [Abstract][Full Text] [Related]
17. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer statistics, 2011.
DeSantis C; Siegel R; Bandi P; Jemal A
CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133
[TBL] [Abstract][Full Text] [Related]
20. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
